[1]
|
Siegel, R.L., Miller, K.D., Fuchs, H.E. and Jemal, A. (2021) Cancer Statistics, 2021. CA: A Cancer Journal for Clini-cians, 71, 7-33. https://doi.org/10.3322/caac.21654
|
[2]
|
Chen, W., Zheng, R., Zhang, S., Zou, X., Zhao, P. and He, J. (2013) Lung Cancer Incidence and Mortality in China, 2009. Thoracic Cancer, 4, 102-108. https://doi.org/10.1111/1759-7714.12025
|
[3]
|
Heng, W.S., Gosens, R. and Kruyt, F.A.E. (2019) Lung Cancer Stem Cells: Origin, Features, Maintenance Mechanisms and Therapeutic Targeting. Biochemical Pharmacology, 160, 121-133. https://doi.org/10.1016/j.bcp.2018.12.010
|
[4]
|
Tsukamoto, M., Iinuma, H., Yagi, T., Matsuda, K. and Hashiguchi, Y. (2017) Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer. Oncology, 92, 360-370. https://doi.org/10.1159/000463387
|
[5]
|
Mäbert, K., Cojoc, M., Peitzsch, C., Kurth, I., Souchelnytskyi, S. and Dubrovska, A. (2014) Cancer Biomarker Discovery: Current Status and Future Perspectives. In-ternational Journal of Radiation Biology, 90, 659-677.
https://doi.org/10.3109/09553002.2014.892229
|
[6]
|
Shao, C., Yang, F., Qin, Z., Jing, X., Shu, Y. and Shen, H. (2019) The Value of miR-155 as a Biomarker for the Diagnosis and Prognosis of Lung Cancer: A Systematic Review with Meta-Analysis. BMC Cancer, 19, Article No. 1103.
https://doi.org/10.1186/s12885-019-6297-6
|
[7]
|
Yang, G., Lu, Z., Meng, F., Wan, Y., Zhang, L., Xu, Q., et al. (2022) Circulating miR-141 as a Potential Biomarker for Diagnosis, Prognosis and Therapeutic Targets in Gallbladder Cancer. Scientific Reports, 12, Article No. 10072.
https://doi.org/10.1038/s41598-022-13430-8
|
[8]
|
楚治良, 常宏宇, 龚慧, 赵光. microRNA生物标志物在结直肠癌诊疗中的应用[J]. 结直肠肛门外科, 2022, 28(1): 30-33.
|
[9]
|
Mohr, A.M. and Mott, J.L. (2015) Overview of MicroRNA Biology. Seminars in Liver Disease, 35, 3-11.
https://doi.org/10.1055/s-0034-1397344
|
[10]
|
Armand-Labit, V. and Pradines, A. (2017) Circulating Cell-Free Mi-croRNAs as Clinical Cancer Biomarkers. Biomolecular Concepts, 8, 61-81. https://doi.org/10.1515/bmc-2017-0002
|
[11]
|
Sun, F.B., Lin, Y., Li, S.J., Gao, J., Han, B. and Zhang, C.S. (2018) MiR-210 Knockdown Promotes the Development of Pancreatic Cancer via Upregulating E2F3 Expression. European Review for Medical and Pharmacological Sciences, 22, 8640-8648. https://doi.org/10.26355/eurrev_201812_16628
|
[12]
|
Zhang, C., Tian, W., Meng, L., Qu, L. and Shou, C. (2016) PRL-3 Promotes Gastric Cancer Migration and Invasion through a NF-κB-HIF-1α-miR-210 Axis. Journal of Molecular Medicine, 94, 401-415.
https://doi.org/10.1007/s00109-015-1350-7
|
[13]
|
Reitsma, J.B., Moons, K.G., Bossuyt, P.M. and Linnet, K. (2012) Systematic Reviews of Studies Quantifying the Accuracy of Diagnostic Tests and Markers. Clinical Chemistry, 58, 1534-1545.
https://doi.org/10.1373/clinchem.2012.182568
|
[14]
|
Whiting, P.F., Rutjes, A.W., Westwood, M.E., Mallett, S., Deeks, J.J., Reitsma, J.B., et al. (2011) QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accu-racy Studies. Annals of Internal Medicine, 155, 529-536.
https://doi.org/10.7326/0003-4819-155-8-201110180-00009
|
[15]
|
Raponi, M., Dossey, L., Jatkoe, T., Wu, X., Chen, G., Fan, H., et al. (2009) MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer. Cancer Research, 69, 5776-5783.
https://doi.org/10.1158/0008-5472.CAN-09-0587
|
[16]
|
Higgins, J.P. and Thompson, S.G. (2002) Quantifying Heterogeneity in a Meta-Analysis. Statistics in Medicine, 21, 1539-1558. https://doi.org/10.1002/sim.1186
|
[17]
|
Deeks, J.J., Macaskill, P. and Irwig, L. (2005) The Performance of Tests of Publication Bias and Other Sample Size Effects in Systematic Reviews of Diagnostic Test Accuracy Was Assessed. Journal of Clinical Epidemiology, 58, 882-893.
https://doi.org/10.1016/j.jclinepi.2005.01.016
|
[18]
|
Zamora, J., Abraira, V., Muriel, A., Khan, K. and Coo-marasamy, A. (2006) Meta-DiSc: A Software for Meta-Analysis of Test Accuracy Data. BMC Medical Research Meth-odology, 6, Article No. 31.
https://doi.org/10.1186/1471-2288-6-31
|
[19]
|
Liu, C., Kannisto, E., Yu, G., Yan, Y., Reid, M.E., Patnaik, S.K., et al. (2020) Non-invasive Detection of Exosomal MicroRNAs via Tethered Cationic Lipoplex Nanoparticles (tCLN) Bio-chip for Lung Cancer Early Detection. Frontiers in Genetics, 11, Article No. 258. https://doi.org/10.3389/fgene.2020.00258
|
[20]
|
Xi, K.X., Zhang, X.W., Yu, X.Y., Wang, W.D., Xi, K.X., Chen, Y.Q., et al. (2018) The Role of Plasma miRNAs in the Diagnosis of Pulmonary Nodules. Journal of Thoracic Disease, 10, 4032-41. https://doi.org/10.21037/jtd.2018.06.106
|
[21]
|
Leng, Q., Lin, Y., Zhan, M. and Jiang, F. (2018) An Integromic Signature for Lung Cancer Early Detection. Oncotarget, 9, 24684-24692. https://doi.org/10.18632/oncotarget.25227
|
[22]
|
Wang, X., Zhi, X., Zhang, Y., An, G. and Feng, G. (2016) Role of Plasma MicroRNAs in the Early Diagnosis of Non-Small-Cell Lung Cancers: A Case-Control Study. Journal of Tho-racic Disease, 8, 1645-1652.
https://doi.org/10.21037/jtd.2016.06.21
|
[23]
|
Świtlik, W.Z., Karbownik, M.S., Suwalski, M., Kozak, J., Szemraj, J., et al. (2019) Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study. Genetic Testing and Molecular Biomarkers, 23, 353-358. https://doi.org/10.1089/gtmb.2018.0275
|
[24]
|
Li, Z.H., Zhang, H., Yang, Z.G., Wen, G.Q., Cui, Y.B. and Shao, G.G. (2013) Prognostic Significance of Serum MicroRNA-210 Levels in Nonsmall-Cell Lung Cancer. Journal of International Medical Research, 41, 1437-1444.
https://doi.org/10.1177/0300060513497560
|
[25]
|
王鑫, 张毅, 胡牧, 姚舒洋, 李小雪, 支修益. 血浆微RNA对早期非小细胞肺癌诊断价值的临床研究[J]. 肿瘤研究与临床, 2017, 29(7): 442-446+452.
|
[26]
|
夏贤斌. 肺癌患者血浆miRNA-20a和miRNA-210表达的诊断意义[硕士学位论文]. 镇江: 江苏大学; 2017.
|
[27]
|
赵宝祥, 李华, 张亚君, 王雪辉. 血清癌胚抗原、神经元特异性烯醇化酶、microRNA-20a和microRNA-210联合检测对早期小细胞肺癌的诊断价值[J]. 新乡医学院学报, 2019, 36(5): 452-454.
|
[28]
|
Zhu, W., Zhou, K., Zha, Y., Chen, D., He, J., Ma, H., et al. (2016) Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer. PLOS ONE, 11, Article ID: e0153046. https://doi.org/10.1371/journal.pone.0153046
|
[29]
|
Wang, J., Yan, F., Zhao, Q., Zhan, F., Wang, R., Wang, L., et al. (2017) Circulating Exosomal miR-125a-3p as a Novel Biomarker for Early-Stage Colon Cancer. Scientific Reports, 7, Article No. 4150.
https://doi.org/10.1038/s41598-017-04386-1
|
[30]
|
Świtlik, W., Karbownik, M.S., Suwalski, M., Kozak, J. and Szemraj, J. (2018) miR-30a-5p Together with miR-210-3p as a Promising Biomarker for Non-Small Cell Lung Cancer: A Preliminary Study. Cancer Biomarkers, 21, 479-488.
https://doi.org/10.3233/CBM-170767
|
[31]
|
Cui, H., Seubert, B., Stahl, E., Dietz, H., Reuning, U., Moreno-Leon, L., et al. (2015) Tissue Inhibitor of Metalloproteinases-1 Induces a Pro-Tumourigenic Increase of miR-210 in Lung Ad-enocarcinoma Cells and Their Exosomes. Oncogene, 34, 3640-3650. https://doi.org/10.1038/onc.2014.300
|
[32]
|
Ju, S., Liang, Z., Li, C., Ding, C., Xu, C., Song, X., et al. (2019) The Effect and Mechanism of miR-210 in Down-Regulating the Autophagy of Lung Cancer Cells. Pathology - Research and Practice, 215, 453-458.
https://doi.org/10.1016/j.prp.2018.12.018
|